Oppenheimer Downgrades Opthea Ltd. (OPT) to Perform Mar 24, 2025 12:56PM
Opthea (OPT) Announces Phase 2b Wet AMD Publication Mar 3, 2025 07:01AM
Opthea (OPT) Announces Publication in Diabetic Macular Edema Jan 7, 2025 07:04AM
Opthea (OPT) Appoints Kathy Connell to its Board Nov 15, 2024 07:01AM
Opthea (OPT) announced three senior hires Oct 8, 2024 07:01AM


Sep 18, 2024 07:30AM Opthea (OPT) Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept
Sep 5, 2024 06:11AM Opthea (OPT) Announces Executive Changes
Sep 3, 2024 06:41AM Opthea Ltd. (OPT) PT Lowered to $12 at H.C. Wainwright
Jul 17, 2024 07:16AM Opthea (OPT) Forms Medical Advisory Board